Brainsway Ltd
TASE:BWAY
Brainsway Ltd
Cash Equivalents
Brainsway Ltd
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
B
|
Brainsway Ltd
TASE:BWAY
|
Cash Equivalents
$48.1m
|
CAGR 3-Years
48%
|
CAGR 5-Years
15%
|
CAGR 10-Years
10%
|
|
Nano-X Imaging Ltd
NASDAQ:NNOX
|
Cash Equivalents
$56.4m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Inmode Ltd
NASDAQ:INMD
|
Cash Equivalents
$164.8m
|
CAGR 3-Years
34%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
||
Sisram Medical Ltd
HKEX:1696
|
Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
S
|
Sofwave Medical Ltd
TASE:SOFW
|
Cash Equivalents
$24.4m
|
CAGR 3-Years
110%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
E
|
Epitomee Medical Ltd
TASE:EPIT
|
Cash Equivalents
$15.6m
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Brainsway Ltd
Glance View
Brainsway Ltd. is a commercial stage medical device company, which focuses on the development and sale of non-invasive neuromodulation products using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
See Also
What is Brainsway Ltd's Cash Equivalents?
Cash Equivalents
48.1m
USD
Based on the financial report for Sep 30, 2024, Brainsway Ltd's Cash Equivalents amounts to 48.1m USD.
What is Brainsway Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
10%
Over the last year, the Cash Equivalents growth was 10%. The average annual Cash Equivalents growth rates for Brainsway Ltd have been 48% over the past three years , 15% over the past five years , and 10% over the past ten years .